Welcome to our dedicated page for Quidel SEC filings (Ticker: QDEL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QuidelOrtho Corporation filings document an in vitro diagnostics company with Nasdaq-listed common stock under QDEL. Form 8-K disclosures cover quarterly and annual operating results, preliminary revenue estimates, financial guidance, Regulation FD communications and business commentary tied to point-of-care, labs, respiratory, cardiac and immunohematology diagnostics.
The company’s proxy and governance filings address annual meeting matters, board composition, executive compensation and shareholder voting information. Other current reports record leadership transitions, director changes, registered securities information and exhibit-based disclosures furnished with earnings releases and stockholder communications.